Entelos Announces Expanded Collaboration With Johnson & Johnson Pharmaceutical Research & Development
20-Mar-2006
As previously reported, J&JPRD is already using Entelos models to validate targets, select biomarkers, and optimize clinical trials for type II diabetes, obesity, and anemia.
Topics
Organizations
Entelos
Johnson & Johnson
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.